Effectiveness of Single vs Multiple Doses of Prophylactic Intravenous Antibiotics in Implant-Based Breast Reconstruction

  17 September 2022

Do rates of postoperative surgical site infections after implant-based breast reconstruction improve when using a multiple-dose instead of a single-dose prophylactic antibiotic regimen?

In this randomized clinical trial, there were no differences in rates of postoperative infections among patients managed with single vs multiple doses of prophylactic antibiotics; multiple doses were associated with higher rates of adverse events.

Multiple-dose intravenous antibiotic prophylaxis is not superior to a single-dose regimen in preventing postoperative infection after implant-based breast reconstruction and is not recommended because of the associated higher rates of adverse events.

Further reading: JAMA Network Open
Author(s): Jessica Gahm et al
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed